Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile
Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de, Andrés Bustamante, Aldo Gaggero, Fabio Paredes, Claudia P. Cortés, Sergio Pantano, Constanza Martínez-Valdebenito, Jenniffer Angulo, Nicole Le Corre, Marcela Ferrés, Marcelo A. Navarrete, Fernando Valiente‐Echeverría, Ricardo Soto‐Rifo
Topics & Concepts
Spike ProteinNeutralizationAntibodyVero cellNeutralizing antibodyVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immune escapeHuman immunodeficiency virus (HIV)BiologyVirusMedicineCoronavirus disease 2019 (COVID-19)Immune systemImmunologyInfectious disease (medical specialty)Internal medicineDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing